Clinical Trials on Acute Peripheral Vestibulopathy in Australia

Total 893 results

Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II (ACTIVATEII)

PAD - Peripheral Arterial Disease

Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia
St George Hospital, Australia
St George & Sutherland Medical Research Foundation

Unknown

A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain (SCIATICA)

Acute Sciatica

Australia
Biotronik CRC Inc.
Biotronik AG

Completed

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Sonnet BioTherapeutics

Terminated

SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Australia
SIMR (Australia) Biotech Pty Ltd.

Completed

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

Peripheral Neuropathic Pain

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Biotronik CRC Inc.

Recruiting

BRight Pharmacokinetic Study

Peripheral Artery Disease

Australia
Actinogen Medical
ICON plc

Completed

Xanamem™ in Healthy Elderly Subjects (XanaHES)

Cognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre Neuropathy

Australia
Monash University
Monash Health

Recruiting

Carnosine for Peripheral Vascular Disease (Car-PVD)

Peripheral Arterial Disease

Australia
Biotronik AG

Active, not recruiting

BIO REsponse Adapted Combination Therapy Pilot Study

Peripheral Arterial Disease

Australia, Belgium, France, Germany, Austria, Spain
Bayside Health
National Health and Medical Research Council, Australia

Terminated

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Bayside Health

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
Lateral Pharma Pty Ltd
Southern Star Research Pty Ltd.

Completed

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

Radiculopathy Lumbar

Australia
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
Symic Vascular
Symic Biomedical, Inc.

Unknown

Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis (SHIELD)

Peripheral Arterial Disease

Australia, New Zealand
R.P.Herrmann
Royal Perth Hospital

Unknown

Mesenchymal Stromal Cells for Acute Graft Versus Host Disease

Acute GVH Disease

Australia
Monash University
Novartis Pharmaceuticals

Recruiting

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) (v-ASCERTAIN)

Cerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)

Australia
Vienna Hospital Association

Completed

High Tone Therapy for Chemotherapy Induced Neuropathy

Electrical Stimulation | Chemotherapy-induced Peripheral Neuropathy

Austria
Shockwave Medical, Inc.

Completed

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)

Peripheral Arterial Disease | Vascular Disease, Peripheral

New Zealand, Australia, United States
Vienna Hospital Association

Recruiting

The Mamma HiToP Study

Chemotherapy-induced Peripheral Neuropathy

Austria
University of Adelaide

Unknown

Minocycline for the Prevention of Post-operative Intercostal Neuralgia

Post-operative Intercostal Neuralgia

Australia
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
Biogen

Completed

Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants

Sciatica

Australia
CSL Limited

Completed

Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)

Australia
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
Baker Heart and Diabetes Institute

Terminated

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

Australia
Medical University of Vienna

Unknown

Exercise Training Versus Best Medical Treatment Only in Peripheral Artery Disease

Peripheral Artery Disease

Austria
Becton, Dickinson and Company
Griffith University

Completed

Impact of PIVC Length and Gauge on Catheter Indwell Time

Indication for Peripheral Intravenous Catheterisation

Australia
The University of Queensland
University of Alabama, Tuscaloosa

Not yet recruiting

Mind-body Therapies for Injury-related Pain Management in Elite Athletes

Pain, Acute

Australia
Cook Group Incorporated

Completed

Zilver PTX Delivery System

Peripheral Vascular Disease

New Zealand, Australia, Germany
Ludwig Boltzmann Gesellschaft

Recruiting

Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

Peripheral Nerve Injury

Austria
Lin BioScience, Inc
Lin BioScience Pty Ltd

Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

Relapsed or Resistant Acute Leukaemias

Taiwan, Australia
Medical University Innsbruck

Recruiting

Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy

Chemotherapeutic Toxicity | Chemotherapy-induced Peripheral Neuropathy | Chemotherapeutic Agent Toxicity

Austria
Royal Brisbane and Women's Hospital

Unknown

Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change

Phlebitis

Australia
Bayside Health

Unknown

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Australia
Vienna General Hospital

Completed

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Peripheral Vascular Diseases | Intermittent Claudication | Angioplasty

Austria
Imago BioSciences, Inc., a subsidiary of Merck...

Completed

A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Australia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Chemotherapy-Induced Peripheral Neuropathy

Australia, Germany, Italy, Spain, Korea, Republic of, Taiwan
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)

Peripheral Arterial Disease

Austria
The George Institute
ANZICS Clinical Trials Group

Completed

Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).

Acute Renal Failure

Australia
University of Sydney
Melbourne Health; Royal Brisbane and Women's Hospital

Unknown

Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation (SCRAMBLE)

Acute Myeloid Leukaemia

Australia
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study (TOBABTK)

Peripheral Artery Disease | Critical Limb Ischemia

Austria
Hoffmann-La Roche

Completed

A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Peripheral Arterial Disease (PAD)

United States, Canada, Australia
Bayside Health
Gilead Sciences

Unknown

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Acute Myeloid Leukemia

Australia
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

Leukemia

Australia

Clinical Trials on Acute Peripheral Vestibulopathy in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations